Hypertrophic Cardiomyopathy (HCM) Panel
New York
Approved
Genes
Conditions
- Danon Disease
- Fabry Disease
- Hypertrophic Cardiomyopathy (HCM)
- Noonan Syndrome
- Pompe Disease
- Transthyretin Amyloidosis
- Wolff-Parkinson-White Syndrome
Clinical Utility
- Confirmation of clinical diagnosis in symptomatic patients
- Genetic counseling and risk assessment of asymptomatic family members of a proband with HCM
- Differentiation of hereditary HCM associated with mutations in sarcomeric genes from phenocopies (i.e. Danon disease, Fabry disease, Noonan syndrome, Pompe disease, Amyloidosis)
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Test Code
J553
CPT Codes*
81439x1
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing